Clinical Management of Acute HIV Infection: Best Practice Remains Unknown

被引:42
作者
Bell, Sigall K. [2 ]
Little, Susan J. [3 ]
Rosenberg, Eric S. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[3] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; TRANSMITTED DRUG-RESISTANCE; T-CELL RESPONSES; VIRAL LOAD; TYPE-1; INFECTION; RESTORATION; ZIDOVUDINE; IMPACT; REPLICATION;
D O I
10.1086/655655
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Best practice for the clinical management of acute human immunodeficiency virus (HIV) infection remains unknown. Although some data suggest possible immunologic, virologic, or clinical benefit of early treatment, other studies show no difference in these outcomes over time, after early treatment is discontinued. The literature on acute HIV infection is predominantly small nonrandomized studies, which further limits interpretation. As a result, the physician is left to grapple with these uncertainties while making clinical decisions for patients with acute HIV infection. Here we review the literature, focusing on the potential advantages and disadvantages of treating acute HIV infection outlined in treatment guidelines, and summarize the presentations on clinical management of acute HIV infection from the 2009 Acute HIV Infection Meeting in Boston, Massachusetts.
引用
收藏
页码:S278 / S288
页数:11
相关论文
共 73 条
  • [1] Primary care guidelines for the management of persons infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
    Aberg, JA
    Gallant, JE
    Anderson, J
    Oleske, JM
    Libman, H
    Currier, JS
    Stone, VE
    Kaplan, JE
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) : 609 - 629
  • [2] Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease
    Al-Harthi, L
    Siegel, J
    Spritzler, J
    Pottage, J
    Agnoli, M
    Landay, A
    [J]. AIDS, 2000, 14 (07) : 761 - 770
  • [3] Tolerability and Efficacy of PI Versus NNRTI-Based Regimens in Subjects Receiving HAART During Acute or Early HIV Infection
    Apuzzo, Linda G.
    Vaida, Florin
    Gallant, Joel E.
    Ernstron, Karin B.
    Little, Susan J.
    Routy, Jean-Pierre
    Collier, Ann C.
    Conway, Brian
    Markowitz, Martin H.
    Hecht, Frederick M.
    Walker, Bruce D.
    Connick, Elizabeth
    Margolick, Joseph B.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) : 267 - 275
  • [4] Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination Antiretroviral therapy in the EuroSIDA study
    Bannister, Wendy P.
    Cozzi-Lepri, Alessandro
    Clotet, Bonaventura
    Mocroft, Amanda
    Kjaer, Jesper
    Reiss, Peter
    von Wyl, Viktor
    Lazzarin, Adriano
    Katlama, Christine
    Phillips, Andrew N.
    Ruiz, Lidia
    Lundgren, Jens D.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (03) : 324 - 333
  • [5] Bell Sigall K, 2009, N Engl J Med, V360, P1540, DOI 10.1056/NEJMcpc0810840
  • [6] Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
    Bennett, Diane E.
    Camacho, Ricardo J.
    Otelea, Dan
    Kuritzkes, Daniel R.
    Fleury, Herve
    Kiuchi, Mark
    Heneine, Walid
    Kantor, Rami
    Jordan, Michael R.
    Schapiro, Jonathan M.
    Vandamme, Anne-Mieke
    Sandstrom, Paul
    Boucher, Charles A. B.
    van de Vijver, David
    Rhee, Soo-Yon
    Liu, Tommy F.
    Pillay, Deenan
    Shafer, Robert W.
    [J]. PLOS ONE, 2009, 4 (03):
  • [7] High rates of forward transmission events after acute/early HIV-1 infection
    Brenner, Bluma G.
    Roger, Michel
    Routy, Jean-Pierre
    Moisi, Daniela
    Ntemgwa, Michel
    Matte, Claudine
    Baril, Jean-Guy
    Thomas, Rejean
    Rouleau, Danielle
    Bruneau, Julie
    Leblanc, Roger
    Legault, Mario
    Tremblay, Cecile
    Charest, Hugues
    Wainberg, Mark A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07) : 951 - 959
  • [8] Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
    Chiappini, E
    Galli, L
    Tovo, PA
    Gabiano, C
    Gattinara, GC
    Guarino, A
    Baddato, R
    Giaquinto, C
    Lisi, C
    de Martino, M
    [J]. AIDS, 2006, 20 (02) : 207 - 215
  • [9] Clements Mark, 2003, HIV Med, V4, P332
  • [10] *DEP HLTH HUM SERV, 2009, GUID AD AD WORK GROU